The potential risk of AVM rupture was evaluated within the A Randomized trial of Unruptured Brain Arteriovenous malformations (ARUBA) trial. This review unveiled a decreased risk of stroke and mortality in sufferers managed conservatively as opposed to individuals who underwent interventional therapy.[13]  The ARUBA demo in comparison healthcare administration by https://www.sgvascularctr.com/service/vascular-malformations/